Highlight
CBT-I significantly improves insomnia severity, sleep efficiency, and sleep onset latency in adults with chronic diseases such as cancer, chronic pain, and stroke. Treatment acceptability is high with low dropout rates and rare adverse effects. Effect sizes are comparable to those seen in general populations without chronic illness.
